This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
OncoTherapy Science, Inc.
Drug Names(s): OTS167IV, OTS167PO
Description: OTS167 is a targeted compound that has a potent inhibitory activity on MELK (maternalembryonic leucine zeipper kinase), a novel protein kinase in formation and maintenance of cancerstem cells. Experiments using xenograft mice models have demonstrated that OTS167 shows potentanti-tumor activities against lung, prostate, breast and pancreatic cancers.
Pink Sheet Weekly Trademark Review July 19, 2016
Pink Sheet Weekly Trademark Review July 12, 2016
Additional information available to subscribers only: